MTOR and metabolic dysfunction-associated steatotic liver disease: Studies have shown that mTORC1 is involved in the mTOR/SREBP-1c/FASN pathway, which is a key pathway involved in regulation of cellular lipid metabolism and is closely associated with the development of NAFLD (Yi et al., 2020).